303 related articles for article (PubMed ID: 31089983)
21. β-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells.
Yu W; Li L; Zheng F; Yang W; Zhao S; Tian C; Yin W; Chen Y; Guo W; Zou L; Deng W
Cell Physiol Biochem; 2017; 44(2):467-478. PubMed ID: 29141249
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of β-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines.
Chang HW; Lee YS; Nam HY; Han MW; Kim HJ; Moon SY; Jeon H; Park JJ; Carey TE; Chang SE; Kim SW; Kim SY
Cell Signal; 2013 Apr; 25(4):839-47. PubMed ID: 23280187
[TBL] [Abstract][Full Text] [Related]
23. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
[TBL] [Abstract][Full Text] [Related]
24. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
[TBL] [Abstract][Full Text] [Related]
25. The combinatorial inhibition of Wnt signaling and Akt kinase is beneficial for reducing the survival and glycolytic activity of tongue cancer cells.
Kleszcz R; Paluszczak J
J Oral Pathol Med; 2022 Mar; 51(3):231-239. PubMed ID: 34358376
[TBL] [Abstract][Full Text] [Related]
26. Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma.
Roy S; Kar M; Roy S; Saha A; Padhi S; Banerjee B
Cell Oncol (Dordr); 2018 Apr; 41(2):185-200. PubMed ID: 29243047
[TBL] [Abstract][Full Text] [Related]
27. Wnt/β-catenin/Slug pathway contributes to tumor invasion and lymph node metastasis in head and neck squamous cell carcinoma.
Moon JH; Lee SH; Lim YC
Clin Exp Metastasis; 2021 Apr; 38(2):163-174. PubMed ID: 33630219
[TBL] [Abstract][Full Text] [Related]
28. Isoorientin inhibits epithelial-to-mesenchymal properties and cancer stem-cell-like features in oral squamous cell carcinoma by blocking Wnt/β-catenin/STAT3 axis.
Liu SC; Huang CS; Huang CM; Hsieh MS; Huang MS; Fong IH; Yeh CT; Lin CC
Toxicol Appl Pharmacol; 2021 Aug; 424():115581. PubMed ID: 34019859
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells.
Kim H; Seo EM; Sharma AR; Ganbold B; Park J; Sharma G; Kang YH; Song DK; Lee SS; Nam JS
Int J Oncol; 2013 Oct; 43(4):1319-25. PubMed ID: 23900432
[TBL] [Abstract][Full Text] [Related]
30. Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in Head and Neck Squamous Cell Carcinoma via the Rac1/Wnt/β-catenin Pathway.
Yu BY; Shi LG; Jiang C; Wang GK; Liu J; Wu TY
Lab Invest; 2023 Jul; 103(7):100134. PubMed ID: 36990154
[TBL] [Abstract][Full Text] [Related]
31. SOX9 regulated proliferation and apoptosis of human lung carcinoma cells by the Wnt/β-catenin signaling pathway.
Guo YZ; Xie XL; Fu J; Xing GL
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4898-4907. PubMed ID: 30070325
[TBL] [Abstract][Full Text] [Related]
32. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
[TBL] [Abstract][Full Text] [Related]
33. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.
Liu J; Pan S; Hsieh MH; Ng N; Sun F; Wang T; Kasibhatla S; Schuller AG; Li AG; Cheng D; Li J; Tompkins C; Pferdekamper A; Steffy A; Cheng J; Kowal C; Phung V; Guo G; Wang Y; Graham MP; Flynn S; Brenner JC; Li C; Villarroel MC; Schultz PG; Wu X; McNamara P; Sellers WR; Petruzzelli L; Boral AL; Seidel HM; McLaughlin ME; Che J; Carey TE; Vanasse G; Harris JL
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20224-9. PubMed ID: 24277854
[TBL] [Abstract][Full Text] [Related]
34. HMQ-T-F5 (1-(4-(2-aminoquinazolin-7-yl)phenyl)-3-(2‑bromo‑5- (trifluoromethoxy)phenyl) thiourea) suppress proliferation and migration of human cervical HeLa cells via inhibiting Wnt/β-catenin signaling pathway.
Dai B; Yang T; Shi X; Ma N; Kang Y; Zhang J; Zhang Y
Phytomedicine; 2018 Dec; 51():48-57. PubMed ID: 30466627
[TBL] [Abstract][Full Text] [Related]
35. Insulin activates hepatic Wnt/β-catenin signaling through stearoyl-CoA desaturase 1 and Porcupine.
Cabrae R; Dubuquoy C; Caüzac M; Morzyglod L; Guilmeau S; Noblet B; Fève B; Postic C; Burnol AF; Moldes M
Sci Rep; 2020 Mar; 10(1):5186. PubMed ID: 32198362
[TBL] [Abstract][Full Text] [Related]
36. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
[TBL] [Abstract][Full Text] [Related]
37. The Significance of the Dysregulation of Canonical Wnt Signaling in Head and Neck Squamous Cell Carcinomas.
Paluszczak J
Cells; 2020 Mar; 9(3):. PubMed ID: 32183420
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of CD44 sensitizes cisplatin-resistance and affects Wnt/β-catenin signaling in HNSCC cells.
Roy S; Kar M; Roy S; Padhi S; Kumar A; Thakur S; Akhter Y; Gatto G; Banerjee B
Int J Biol Macromol; 2020 Apr; 149():501-512. PubMed ID: 31953176
[TBL] [Abstract][Full Text] [Related]
39. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
[TBL] [Abstract][Full Text] [Related]
40. CUL4B promotes aggressive phenotypes of HNSCC via the activation of the Wnt/β-catenin signaling pathway.
Wang Y; Yue D
Cancer Med; 2019 May; 8(5):2278-2287. PubMed ID: 30883036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
